Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.
about
Characterization of Lethal Zika Virus Infection in AG129 MiceMouse models of dengue virus infection for vaccine testingProtective efficacy of Zika vaccine in AG129 mouse modelDefining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon ReceptorsMonocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication.The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in MiceReplacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.Vaccines licensed and in clinical trials for the prevention of dengue.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.Zika virus like particles elicit protective antibodies in mice.
P2860
Q24082695-A781C170-0B0A-44D3-902B-99ACACA41AA3Q24276139-83E02F5A-8846-41B9-86EE-70C4882E7B84Q29378065-E8B108B9-2EEC-45A8-8B1B-E6A4A4E233B7Q33425879-87B174B5-A495-44BE-9021-82FA07739AD4Q33429775-05FE0567-008C-4A49-A380-70A928718980Q34634755-37D98D78-77FD-4A4F-9D60-4618FE4E0DB6Q35880666-0BBD982D-5FD2-472A-B5C6-9C7EF19DA0ECQ36234359-14FC4E4F-F8FD-41DD-A366-01DBAF152B64Q36255068-D5DF534F-8973-4B7C-A6A4-8814F8A659FAQ38658737-BC51F5A5-001F-4D14-BA97-7DFD7E453A81Q39172722-1754A491-E8E2-4CBD-8015-F1188871341EQ47562022-5A63DB43-DBBC-4BC3-97F1-3FF01300C152Q48105726-57BB8C01-3DF0-4C63-8F74-5CE97E071B6B
P2860
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Investigating the efficacy of ...... ENV-4 challenge in AG129 mice.
@en
type
label
Investigating the efficacy of ...... ENV-4 challenge in AG129 mice.
@en
prefLabel
Investigating the efficacy of ...... ENV-4 challenge in AG129 mice.
@en
P2093
P2860
P50
P1433
P1476
Investigating the efficacy of ...... ENV-4 challenge in AG129 mice.
@en
P2093
Charalambos D Partidos
Haiyan Chu
Jeremy Fuchs
Nigel Bourne
Peter O'Day
Richard Pyles
Subash C Das
P2860
P304
P356
10.1016/J.VACCINE.2014.08.087
P407
P577
2014-09-17T00:00:00Z